COMPOSITIONS SUITABLE FOR TREATING COLLAGEN-MEDIATED DISEASES

(19)

(11)

EP 1 987 141 B8

(12)	CORRECTED EUROPEAN PATENT SPECIFICATION
	Note: Bibliography reflects the latest situation

(15)	Correction information:
	Corrected version no 1 (W1 B1)

(48)	Corrigendum issued on:
	06.03.2019 Bulletin 2019/10

(45)	Mention of the grant of the patent:
	05.12.2018 Bulletin 2018/49

(21)	Application number: 07762860.0

(22)	Date of filing: 30.01.2007

(51)

International Patent Classification (IPC):

C12N 9/52^(2006.01)

C12N 9/20^(2006.01)

(86)	International application number:
	PCT/US2007/002654

(87)	International publication number:
	WO 2007/089851 (09.08.2007 Gazette 2007/32)

(54)	COMPOSITIONS SUITABLE FOR TREATING COLLAGEN-MEDIATED DISEASES ZUSAMMENSETZUNGEN ZUR BEHANDLUNG COLLAGEN-BEDINGTER KRANKHEITEN COMPOSITIONS DE TRAITEMENT DES MALADIES MÉDIÉES PAR LE COLLAGÈNE

(84)	Designated Contracting States:
	AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
	Designated Extension States:
	AL BA HR MK RS

(30)

Priority:

30.01.2006 US 763470 P
20.03.2006 US 784135 P
29.01.2007 US 699302

(43)	Date of publication of application:
	05.11.2008 Bulletin 2008/45

(60)	Divisional application:
	12155228.5 / 2474319
	12155230.1 / 2474320
	12155233.5 / 2474321
	18209918.4

(73)	Proprietors:
	Endo Global Ventures Hamilton HM12 (BM) BioSpecifics Technologies Corporation Lynbrook, NY 11563 (US)

(72)	Inventors:
	SABATINO, Gregory, L. Chester Springs, PA 19425 (US) DEL TITO, JR., Benjamin, J. Doylestown, PA 18901 (US) BASSETT, Phillip, J. Staffordshire ST5 3AL (GB) THARIA, Hazel, A. Nr Crewe, Cheshire CW2 5RE (GB) HITCHCOCK, Antony, G. Wistaston, Crewe CW2 8HL (GB) YU, Bo New York 11563 (US) WEGMAN, Thomas L. New York 11563 (US)

(74)	Representative: Lee, Nicholas John et al
	Kilburn & Strode LLP Lacon London 84 Theobalds Road London WC1X 8NL London WC1X 8NL (GB)

(56)

References cited: :

WO-A-96/00283
US-A- 5 952 215
US-A1- 2004 137 596

WO-A-98/24889
US-A- 5 989 888
US-B1- 6 475 764

Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).